General Information of Drug (ID: DMFOA6R)

Drug Name
2-(3-Methyl-indole-1-sulfonyl)-benzoic acid
Synonyms CHEMBL361251; 2-(3-Methyl-indole-1-sulfonyl)-benzoic acid
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 315.3
Logarithm of the Partition Coefficient (xlogp) 3.1
Rotatable Bond Count (rotbonds) 3
Hydrogen Bond Donor Count (hbonddonor) 1
Hydrogen Bond Acceptor Count (hbondacc) 4
Chemical Identifiers
Formula
C16H13NO4S
IUPAC Name
2-(3-methylindol-1-yl)sulfonylbenzoic acid
Canonical SMILES
CC1=CN(C2=CC=CC=C12)S(=O)(=O)C3=CC=CC=C3C(=O)O
InChI
InChI=1S/C16H13NO4S/c1-11-10-17(14-8-4-2-6-12(11)14)22(20,21)15-9-5-3-7-13(15)16(18)19/h2-10H,1H3,(H,18,19)
InChIKey
FBAOKNXTXGWCMO-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
44393556
ChEBI ID
CHEMBL361251
TTD ID
D0Y8JN
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Fatty acid-binding protein 4 (FABP4) TTHWMFZ FABP4_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target. Bioorg Med Chem Lett. 2004 Sep 6;14(17):4445-8.